• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFESCAN EUROPE GMBH OT SELECT METER; GLUCOSE MONITORING SYS/KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFESCAN EUROPE GMBH OT SELECT METER; GLUCOSE MONITORING SYS/KIT Back to Search Results
Lot Number 4392866
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Visual Impairment (2138); Dizziness (2194); Confusion/ Disorientation (2553)
Event Type  Injury  
Event Description
On february 5, 2019, the lay user/patient contacted lifescan (lfs) (b)(4), alleging that her onetouch select meter read inaccurately high compared to her feelings and/or normal readings.The complaint was classified based on the customer service representative (csr) documentation.The patient reported that the alleged meter inaccuracy began approximately one month prior to contacting lfs.The patient reported obtaining alleged inaccurate high blood glucose readings between ¿10.6-12.0 mmol/l¿ with the subject meter.Meter to feelings/normal results comparisons do not meet the criteria necessary for lfs to determine an inaccuracy.The patient informed the csr that she manages her diabetes with ¿2 units¿ of glimepiride in combination with diet and exercise.The patient reported that an unspecified time before the alleged inaccuracy began she had developed symptoms of ¿dizziness, feeling of falling and visual impairment¿.The patient reported that in response to the alleged inaccurate high readings obtained with the subject meter she increased her dose of medication from "2 units to 3 or 4 units" of glimepiride.The patient reported that an unspecified time after taking the increased dose of glimepiride she felt ¿worse¿ and performed another test with the subject meter and a result of ¿3.1 mmol/l¿ was obtained.The patient self-treated her symptoms with sweets and reported feeling better.During troubleshooting, the csr noted that the subject meter was set to the correct unit of measure.In addition, the csr confirmed that the patient¿s test strips had been stored correctly and were within their expiry/discard date.The patient did not have control solution to perform a quality control test.Replacement products were sent to the patient.This complaint is being reported because the patient reportedly developed symptoms suggestive of a serious injury adverse event after taking an increased dose of glimepiride in response to alleged inaccurate high results obtained with the subject meter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OT SELECT METER
Type of Device
GLUCOSE MONITORING SYS/KIT
Manufacturer (Section D)
LIFESCAN EUROPE GMBH
gubelstrasse 34
zug 6300
SZ  6300
Manufacturer (Section G)
LIFESCAN EUROPE GMBH
gubelstrasse 34
zug 6300
SZ   6300
Manufacturer Contact
oyinkan donaldson
gubelstrasse 34
zug 6300
SZ   6300
MDR Report Key8334341
MDR Text Key135997404
Report Number3008382007-2019-00419
Device Sequence Number1
Product Code CGA
Combination Product (y/n)Y
PMA/PMN Number
K072543
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial
Report Date 02/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Lot Number4392866
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date02/05/2019
Initial Date Manufacturer Received 02/05/2019
Initial Date FDA Received02/13/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-